This work is licensed under the Creative Commons Attribution 4.0 International License.
Testa R, Bonfigli AR, Prattichizzo F, La Sala L, De Nigris V, Ceriello A. The “Metabolic Memory” Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications. Vol. 9, Nutrients. 2017.TestaRBonfigliARPrattichizzoFLa SalaLDe NigrisVCerielloAThe “Metabolic Memory” Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications9Nutrients201710.3390/nu9050437545216728452927Search in Google Scholar
Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation. 2002;105(14):1656–62.GuzikTJMussaSGastaldiDSadowskiJRatnatungaCPillaiRMechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthaseCirculation.20021051416566210.1161/01.CIR.0000012748.58444.0811940543Search in Google Scholar
F Giacco MB. Oxidative stress and diabetic complications. Giacco F1, Brownlee M. Circ Res. 2010;F GiaccoMBOxidative stress and diabetic complicationsGiacco F1, Brownlee M. Circ Res201010.1161/CIRCRESAHA.110.223545299692221030723Search in Google Scholar
Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. In: Diabetes. 2005. p. 1615–25.BrownleeMThe pathobiology of diabetic complications: A unifying mechanismIn:Diabetes200516152510.2337/diabetes.54.6.161515919781Search in Google Scholar
Brouwers O, Niessen PM, Haenen G, Miyata T, Brownlee M, Stehouwer CD, et al. Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia. 2010;53(5):989–1000.BrouwersONiessenPMHaenenGMiyataTBrownleeMStehouwerCDHyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stressDiabetologia.2010535989100010.1007/s00125-010-1677-0285052420186387Search in Google Scholar
M. N, A. S, B. S, T. G, T. H, C. G, et al. Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. American Journal of Clinical Nutrition. 2007.NM.SA.SB.GT.HT.GC.Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitusAmerican Journal of Clinical Nutrition2007Search in Google Scholar
Yamagishi SI. Advanced Glycation End-Products. In: Brenner's Encyclopedia of Genetics: Second Edition. 2013. p. 36–8.YamagishiSIAdvanced Glycation End-ProductsIn:Brenner's Encyclopedia of Genetics: Second Edition201336810.1016/B978-0-12-374984-0.00476-9Search in Google Scholar
Tanaka N, Yonekura H, Yamagishi SI, Fujimori H, Yamamoto Y, Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-α through nuclear factor-κB, and by 17β-Estradiol through sp-1 in human vascular endothelial cells. J Biol Chem. 2000;275(33): 25781–90.TanakaNYonekuraHYamagishiSIFujimoriHYamamotoYYamamotoHThe receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-α through nuclear factor-κB, and by 17β-Estradiol through sp-1 in human vascular endothelial cellsJ Biol Chem.200027533257819010.1074/jbc.M00123520010829018Search in Google Scholar
Wang H, Liu J, Wu L. Methylglyoxal-induced mitochondrial dysfunction in vascular smooth muscle cells. Biochem Pharmacol. 2009; 77(11):1709–16.WangHLiuJWuLMethylglyoxal-induced mitochondrial dysfunction in vascular smooth muscle cellsBiochem Pharmacol.2009771117091610.1016/j.bcp.2009.02.02419428325Search in Google Scholar
Shamoon H, Cleary P, Barnie A, Genuth S, Maffin C, Tamborlane W, et al. Epidemiology of Diabetes Interventions and Complications (EDIC): Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care. 1999;22(1):99–111.ShamoonHClearyPBarnieAGenuthSMaffinCTamborlaneWEpidemiology of Diabetes Interventions and Complications (EDIC): Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohortDiabetes Care.19992219911110.2337/diacare.22.1.99274593810333910Search in Google Scholar
Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes. 1994;43(9):1122–9.XiaPInoguchiTKernTSEngermanRLOatesPJKingGLCharacterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemiaDiabetes.19944391122910.2337/diab.43.9.11228070612Search in Google Scholar
Steinberg SF. Structural basis of protein kinase C isoform function. Vol. 88, Physiological Reviews. 2008. p. 1341–78.SteinbergSFStructural basis of protein kinase C isoform function88Physiological Reviews200813417810.1152/physrev.00034.2007289968818923184Search in Google Scholar
Ganz MB, Seftel A. Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E. Am J Physiol - Endocrinol Metab. 2000;278(1 41–1).GanzMBSeftelAGlucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin EAm J Physiol - Endocrinol Metab2000278141110.1152/ajpendo.2000.278.1.E14610644549Search in Google Scholar
Pugliese G, Pricci F, Pugliese F, Mene P, Lenti L, Andrean D, et al. Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes. 1994;43(3):478–90.PuglieseGPricciFPuglieseFMenePLentiLAndreanDMechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cellsDiabetes.19944334789010.2337/diab.43.3.4788314022Search in Google Scholar
Takagi C, Bursell SE, Lin YW, Takagi H, Duh E, Jiang Z, et al. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Investig Ophthalmol Vis Sci. 1996;37(12):2504–18.TakagiCBursellSELinYWTakagiHDuhEJiangZRegulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1Investig Ophthalmol Vis Sci.19963712250418Search in Google Scholar
Shiba T, Inoguchi T, Sportsman JR, Heath WF, Bursell S, King GL. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol - Endocrinol Metab. 1993;265(5 28–5).ShibaTInoguchiTSportsmanJRHeathWFBursellSKingGLCorrelation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulationAm J Physiol - Endocrinol Metab1993265528510.1152/ajpendo.1993.265.5.E7838238505Search in Google Scholar
Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL. Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest. 1997;100(1):115–26.KoyaDJirousekMRLinYWIshiiHKubokiKKingGLCharacterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic ratsJ Clin Invest.199710011152610.1172/JCI1195035081719202063Search in Google Scholar
KOYA D, HANEDA M, NAKAGAWA H, ISSHIKI K, SATO H, MAEDA S, et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J. 2000;14(3):439–47.KOYADHANEDAMNAKAGAWAHISSHIKIKSATOHMAEDASAmelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetesFASEB J.20001434394710.1096/fasebj.14.3.43910698958Search in Google Scholar
Pugliese G, Tilton RG, Williamson JR. Glucose–induced metabolic imbalances in the pathogenesis of diabetic vascular disease. Diabetes Metab Rev. 1991;7(1):35–59.PuglieseGTiltonRGWilliamsonJRGlucose–induced metabolic imbalances in the pathogenesis of diabetic vascular diseaseDiabetes Metab Rev.199171355910.1002/dmr.56100701061935535Search in Google Scholar
Vikramadithyan RK, Hu Y, Noh HL, Liang CP, Hallam K, Tall AR, et al. Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. J Clin Invest. 2005;115(9):2434–43.VikramadithyanRKHuYNohHLLiangCPHallamKTallARHuman aldose reductase expression accelerates diabetic atherosclerosis in transgenic miceJ Clin Invest.2005115924344310.1172/JCI24819119037116127462Search in Google Scholar
Sayeski PP, Kudlow JE. Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-α gene transcription. J Biol Chem. 1996;271(25):15237–43.SayeskiPPKudlowJEGlucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-α gene transcriptionJ Biol Chem.199627125152374310.1074/jbc.271.25.152378663078Search in Google Scholar
Schleicher ED, Weigert C. Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney International, Supplement. 2000.SchleicherEDWeigertCRole of the hexosamine biosynthetic pathway in diabetic nephropathyKidney International, Supplement200010.1046/j.1523-1755.2000.07703.x10997685Search in Google Scholar
James LR, Tang D, Ingram A, Ly H, Thai K, Cai L, et al. Flux through the hexosamine pathway is a determinant of nuclear factor κB-dependent promoter activation. Diabetes. 2002;51(4):1146–56.JamesLRTangDIngramALyHThaiKCaiLFlux through the hexosamine pathway is a determinant of nuclear factor κB-dependent promoter activationDiabetes.200251411465610.2337/diabetes.51.4.1146Search in Google Scholar
Wang Z, Zhao H, Guan W, Kang X, Tai X, Shen Y. Metabolic memory in mitochondrial oxidative damage triggers diabetic retinopathy. BMC Ophthalmol. 2018;18(1).WangZZhaoHGuanWKangXTaiXShenYMetabolic memory in mitochondrial oxidative damage triggers diabetic retinopathyBMC Ophthalmol.201818110.1186/s12886-018-0921-0Search in Google Scholar
Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Vol. 414, Nature. 2001. p. 813–20.BrownleeMBiochemistry and molecular cell biology of diabetic complications414Nature20018132010.1038/414813aSearch in Google Scholar
Bernardi S, Michelli A, Zuolo G, Candido R, Fabris B. Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease. Journal of Diabetes Research. 2016.BernardiSMichelliAZuoloGCandidoRFabrisBUpdate on RAAS Modulation for the Treatment of Diabetic Cardiovascular DiseaseJournal of Diabetes Research201610.1155/2016/8917578Search in Google Scholar
Wu Y, Tang L, Chen B. Oxidative stress: Implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives. Vol. 2014, Oxidative Medicine and Cellular Longevity. 2014.WuYTangLChenBOxidative stress: Implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives2014Oxidative Medicine and Cellular Longevity201410.1155/2014/752387Search in Google Scholar
Yoshida T, Yamagishi S, Nakamura K, Matsui T, Imaizumi T, Takeuchi M, et al. Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation. Diabetologia. 2006;49(12):3094–9.YoshidaTYamagishiSNakamuraKMatsuiTImaizumiTTakeuchiMTelmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activationDiabetologia.200649123094910.1007/s00125-006-0437-7Search in Google Scholar
Sjølie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, et al. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet. 2008;372(9647):1385–93.SjølieAKKleinRPortaMOrchardTFullerJParvingHHEffect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trialLancet.2008372964713859310.1016/S0140-6736(08)61411-7Search in Google Scholar
Chaturvedi N, Porta M, Klein R, Orchard T, Fuller J, Parving HH, et al. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. Lancet. 2008;372(9647):1394–402.ChaturvediNPortaMKleinROrchardTFullerJParvingHHEffect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trialsLancet.20083729647139440210.1016/S0140-6736(08)61412-9Search in Google Scholar
Miller AG, Tan G, Binger KJ, Pickering RJ, Thomas MC, Nagaraj RH, et al. Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function. Diabetes. 2010;59(12):3208–15.MillerAGTanGBingerKJPickeringRJThomasMCNagarajRHCandesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I functionDiabetes.2010591232081510.2337/db10-0552299278420852029Search in Google Scholar
Silva KC, Rosales MAB, Biswas SK, De Faria JBL, De Faria JML. Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes. Diabetes. 2009;SilvaKCRosalesMABBiswasSKDe FariaJBLDe FariaJMLDiabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetesDiabetes200910.2337/db09-0166268268319289456Search in Google Scholar
Zhang X, Lassila M, Cooper ME, Cao Z. Retinal Expression of Vascular Endothelial Growth Factor Is Mediated by Angiotensin Type 1 and Type 2 Receptors. Hypertension. 2004;43(2 I):276–81.ZhangXLassilaMCooperMECaoZRetinal Expression of Vascular Endothelial Growth Factor Is Mediated by Angiotensin Type 1 and Type 2 ReceptorsHypertension.2004432 I2768110.1161/01.HYP.0000113628.94574.0f14718351Search in Google Scholar
Simão S, Santos DF, Silva GA. Aliskiren decreases oxidative stress and angiogenic markers in retinal pigment epithelium cells. Angiogenesis. 2017;20(1):175–81.SimãoSSantosDFSilvaGAAliskiren decreases oxidative stress and angiogenic markers in retinal pigment epithelium cellsAngiogenesis.20172011758110.1007/s10456-016-9526-527695972Search in Google Scholar
Ceriello A, Assaloni R, Da Ros R, Maier A, Piconi L, Quagliaro L, et al. Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation. 2005;111(19):2518–24.CerielloAAssaloniRDa RosRMaierAPiconiLQuagliaroLEffect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patientsCirculation.20051111925182410.1161/01.CIR.0000165070.46111.9F15867169Search in Google Scholar
Carrillo-Ibarra S, Miranda-Díaz AG, Sifuentes-Franco S, Cardona-Muñoz EG, Rodríguez-Carrizalez AD, Villegas-Rivera G, et al. Effect of statins on oxidative DNA damage in diabetic polyneuropathy. J Circ Biomarkers. 2018;7.Carrillo-IbarraSMiranda-DíazAGSifuentes-FrancoSCardona-MuñozEGRodríguez-CarrizalezADVillegas-RiveraGEffect of statins on oxidative DNA damage in diabetic polyneuropathyJ Circ Biomarkers.2018710.1177/1849454418804099617096130302131Search in Google Scholar
Berezin A. Metabolic memory phenomenon in diabetes mellitus: Achieving and perspectives. Vol. 10, Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2016. p. S176–83.BerezinAMetabolic memory phenomenon in diabetes mellitus: Achieving and perspectives10Diabetes and Metabolic Syndrome: Clinical Research and Reviews2016S1768310.1016/j.dsx.2016.03.01627025794Search in Google Scholar
Zhao S, Li J, Wang N, Zheng B, Li T, Gu Q, et al. Fenofibrate suppresses cellular metabolic memory of high glucose in diabetic retinopathy via a sirtuin 1-dependent signalling pathway. Mol Med Rep. 2015;12(4):6112–8.ZhaoSLiJWangNZhengBLiTGuQFenofibrate suppresses cellular metabolic memory of high glucose in diabetic retinopathy via a sirtuin 1-dependent signalling pathwayMol Med Rep.20151246112810.3892/mmr.2015.416426238659Search in Google Scholar